Philip Casselli - Microbix Biosystems President
| MBX Stock | CAD 0.30 0.01 3.23% |
President
Mr. Philip J. Casselli is Senior Vice President Business Development and Sales, Marketing of the Company. He is primarily responsible for all operational and revenue generating activities within the company. From 2003 to 2007 Phil held the position of General Manager at Microbix and focused on the operational activities and sales for the virology products. Prior to joining Microbix, Phil worked in senior management positions in the hightech software industry and held a variety of positions in sales and application development at Millipore Corporationrationration, a provider of purification technologies to the biotechnology and pharmaceutical industries. He graduated in 1985 from the University of Ottawa with a Bachelor of Applied Science in Chemical Engineering. since 2017.
| Tenure | 7 years |
| Address | 265 Watline Avenue, Mississauga, ON, Canada, L4Z 1P3 |
| Phone | 905 361 8910 |
| Web | https://www.microbix.com |
Microbix Biosystems Management Efficiency
The company has return on total asset (ROA) of 0.0382 % which means that it generated a profit of $0.0382 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2004 %, meaning that it generated $0.2004 on every $100 dollars invested by stockholders. Microbix Biosystems' management efficiency ratios could be used to measure how well Microbix Biosystems manages its routine affairs as well as how well it operates its assets and liabilities. As of the 24th of November 2024, Return On Tangible Assets is likely to drop to -0.0012. In addition to that, Return On Capital Employed is likely to drop to -0.08. At this time, Microbix Biosystems' Asset Turnover is very stable compared to the past year.Management Performance
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0382 |
Microbix Biosystems Leadership Team
Elected by the shareholders, the Microbix Biosystems' board of directors comprises two types of representatives: Microbix Biosystems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Microbix. The board's role is to monitor Microbix Biosystems' management team and ensure that shareholders' interests are well served. Microbix Biosystems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Microbix Biosystems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Cochran, Independent Director | ||
| Philip Casselli, Senior Vice President - Business Development and Sales, Marketing | ||
| Kevin Cassidy, Senior Vice President Sales and Business Development | ||
| William Gastle, Founder, Executive Chairman, Member of Audit Committee and Member of HR, Compensation and Governance Committee | ||
| Mark Luscher, Senior Vice President - Scientific Affairs | ||
| Christopher Lobb, General Officer | ||
| Joseph Renner, Lead, Independent Director | ||
| Kathryn Froh, Vice President - Diagnostics | ||
| Martin Marino, Independent Chairman of the Board | ||
| Cameron Groome, President, Chief Executive Officer, Director | ||
| James Currie, Chief Financial Officer | ||
| Vaughn EmbroPantalony, President CEO, Director | ||
| Kenneth Hughes, Chief Operating Officer | ||
| Peter Blecher, Independent Director |
Microbix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Microbix Biosystems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0382 | ||||
| Profit Margin | 0.22 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 34.56 M | ||||
| Shares Outstanding | 136.7 M | ||||
| Shares Owned By Insiders | 14.01 % | ||||
| Shares Owned By Institutions | 0.43 % | ||||
| Number Of Shares Shorted | 9.02 K | ||||
| Price To Book | 1.46 X |
Pair Trading with Microbix Biosystems
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Microbix Biosystems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbix Biosystems will appreciate offsetting losses from the drop in the long position's value.Moving against Microbix Stock
| 0.88 | WMT | Walmart Inc CDR | PairCorr |
| 0.84 | AMZN | Amazon CDR | PairCorr |
| 0.8 | NVDA | NVIDIA CDR | PairCorr |
| 0.76 | TSLA | Tesla Inc CDR | PairCorr |
| 0.72 | GOOG | Alphabet CDR | PairCorr |
The ability to find closely correlated positions to Microbix Biosystems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microbix Biosystems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microbix Biosystems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microbix Biosystems to buy it.
The correlation of Microbix Biosystems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microbix Biosystems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microbix Biosystems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microbix Biosystems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Microbix Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.